scispace - formally typeset
A

Armando Santoro

Researcher at Humanitas University

Publications -  961
Citations -  56759

Armando Santoro is an academic researcher from Humanitas University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 93, co-authored 847 publications receiving 48505 citations. Previous affiliations of Armando Santoro include Aix-Marseille University & University of Milan.

Papers
More filters
Journal ArticleDOI

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

J. Gligorov, +495 more
TL;DR: SafeHer confirms the safety and tolerability of the H SC 600 mg fixed dose for 1 year (every 3 weeks for 18 cycles) as adjuvant therapy with concurrent or sequential chemotherapy for HER2-positive EBC.
Journal ArticleDOI

Prognostic factors in elderly patients with malignant pleural mesothelioma: results of a multicenter survey

TL;DR: Non-epithelioid histology, age ⩾75 years, advanced IMIG stage and presence of comorbidities according to CCI were significant prognostic factors in elderly patients with MPM.
Journal ArticleDOI

Metastasis of hepatocellular carcinoma to the heart: a case report and review of the literature.

TL;DR: A rare case of right intraventricular metastasis from HCC in a patient who had undergone a partial hepatectomy for HCC more than two years earlier, who died of progressive hepatic failure six months later.
Journal ArticleDOI

Large volume unresectable locally advanced non-small cell lung cancer: acute toxicity and initial outcome results with rapid arc.

TL;DR: RA proved to be a safe and advantageous treatment modality for NSCLC with large volumes and respect most planning objectives on target volumes and organs at risk.
Journal ArticleDOI

Re-irradiation of metastatic spinal cord compression: A feasibility study by volumetric-modulated arc radiotherapy for in-field recurrence creating a dosimetric hole on the central canal

TL;DR: The possibility of using volumetric modulated arc RT by RapidArc was evaluated for dose sparing at spinal cord level and preserving target coverage, and a clinically satisfactory PTV coverage and dose sparing to the spinal cord were obtained.